In last trading session, Ingevity Corp (NYSE:NGVT) saw 0.32 million shares changing hands with its beta currently measuring 1.32. Company’s recent per share price level of $32.88 trading at $0.03 or 0.09% at ring of the bell on the day assigns it a market valuation of $1.20B. That closing price of NGVT’s stock is at a discount of -71.2% from its 52-week high price of $56.29 and is indicating a premium of 13.35% from its 52-week low price of $28.49. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.23 million shares which gives us an average trading volume of 261.28K if we extend that period to 3-months.
For Ingevity Corp (NGVT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.74 in the current quarter.
Ingevity Corp (NYSE:NGVT) trade information
Upright in the green during last session for gaining 0.09%, in the last five days NGVT remained trading in the green while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $32.88 price level, adding 3.83% to its value on the day. Ingevity Corp’s shares saw a change of -19.31% in year-to-date performance and have moved 4.12% in past 5-day. Ingevity Corp (NYSE:NGVT) showed a performance of -24.10% in past 30-days. Number of shares sold short was 1.26 million shares which calculate 4.71 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 47 to the stock, which implies a rise of 30.04% to its current value. Analysts have been projecting 47 as a low price target for the stock while placing it at a high target of 47. It follows that stock’s current price would drop -42.94% in reaching the projected high whereas dropping to the targeted low would mean a loss of -42.94% for stock’s current value.
Ingevity Corp (NGVT) estimates and forecasts
This year revenue growth is estimated to fall -3.58% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 285.47M for the same. And 3 analysts are in estimates of company making revenue of 385.4M in the next quarter. Company posted 340.1M and 390.6M of sales in current and next quarters respectively a year earlier.
In 2025, company’s earnings growth rate is likely to be around 25.57% while estimates for its earnings growth in next 5 years are of 17.97%.
Ingevity Corp (NYSE:NGVT)’s Major holders
Insiders are in possession of 1.10% of company’s total shares while institution are holding 102.49 percent of that, with stock having share float percentage of 103.62%. Investors also watch the number of corporate investors in a company very closely, which is 102.49% institutions for Ingevity Corp that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at NGVT for having 5.67 million shares of worth $247.72 million. And as of 2024-06-30, it was holding 15.5977 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.16 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.4462 of outstanding shares, having a total worth of $181.79 million.
On the other hand, iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 2.25 shares of worth $73.9 million or 6.17% of the total outstanding shares. The later fund manager was in possession of 1.13 shares on Dec 31, 2024 , making its stake of worth around $37.05 million in the company or a holder of 3.09% of company’s stock.
